Figure 4
From: Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer
Suppression of DRAK2 expression by COX-2 in colorectal tumours. (A) DRAK2 expression normalised to 18S (as measured by qRT-PCR) in template extracted from colorectal tumours sampled before and after treatment with the selective COX-2 inhibitor rofecoxib (with a line joining the pre- and post-treatment values for each patient). (B) The log relative fold change in expression (following treatment) of a range of other genes in the same samples for comparison (error bars indicate s.e.m., *P<0.05, **P<0.01; paired Student's t-test).
